Skip to main content
. 2017 Jun 13;7:3337. doi: 10.1038/s41598-017-03419-z

Figure 13.

Figure 13

Analysis of [125I]4-trastuzumab by SDS-PAGE. Left and right panels show CBB staining (A) and autoradiography (B), respectively. [125I]4-trastuzumab (2.5 ng) was subjected to SDS-PAGE (Lane 1). Lane M shows molecular weight markers. Images were cropped to remove extraneous areas.